- Investing Ideas
- /
- German Pharmaceuticals & Biotech Potentially Undervalued Companies
German Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 25, 2024
Companies with a Value score of at least 3, ordered by Value score
468 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SG7 | US$13.13 | 8.8% | -69.0% | US$841.5m | US$21.61 | PS9.2x | E46.2% | n/a | ||
6XC | US$35.64 | 1.8% | 1,049.7% | US$1.3b | US$61.40 | PB7.9x | E60.3% | n/a | ||
VW5 | US$0.24 | -17.3% | -42.3% | US$123.7m | n/a | PB1.8x | E97.9% | n/a | ||
B9A | kr16.63 | -0.5% | -25.0% | kr17.1b | kr31.44 | PE74.6x | E48.2% | 0% | ||
EX9 | US$21.61 | 1.8% | n/a | US$6.9b | US$24.46 | PE33.4x | E22.6% | n/a | ||
8JM | €98.30 | 1.2% | 17.4% | €1.2b | €108.75 | PE20.9x | E5.0% | 0.9% | ||
BM8 | US$80.74 | -4.8% | -4.1% | US$17.3b | US$107.83 | PE75.9x | E29.8% | n/a | ||
8EQ | US$5.35 | n/a | -45.1% | US$736.5m | US$9.50 | PS3.8x | E87.9% | n/a | ||
7XP | US$17.14 | 2.8% | -23.1% | US$4.7b | US$20.01 | PE4.6x | E3.8% | 6.1% | ||
LC8A | kr17.60 | 4.8% | -16.2% | kr5.6b | kr35.17 | PS4.6x | E48.8% | n/a | ||
1GDA | US$4.20 | 1.0% | -9.9% | US$189.2m | US$17.65 | PS6.9x | E63.6% | n/a | ||
IJF | US$286.00 | 5.8% | 65.0% | US$24.8b | US$337.05 | PE36.3x | E14.9% | n/a |